Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-05-031878
Filing Date
2005-06-14
Accepted
2005-06-14 16:46:57
Documents
2
Period of Report
2005-06-10

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bsd10010_bsd5tr.html 4  
1 MAIN DOCUMENT DESCRIPTION bsd10010_bsd5tr.xml 4 6385
2 POWER OF ATTORNEY bsd10010_bsd5trex24.txt EX-24 2120
  Complete submission text file 0001209191-05-031878.txt   10334
Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SMEDENS AGER 6 NORUP DK-7182 BREDSTEN G7 DK-7182
Business Address 45 75 88 35 98
Rasmussen Torsten (Reporting) CIK: 0001291881 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 05895347